The US Food and Drug Administration has approved monoclonal antibody therapies developed by Regeneron to be used on Covid-19 patients, including children and at-risk elderly, to help them avoid hospitalization. The emergency green light was given for casirivimab and imdevimab, two monoclonal antibodies developed by Regeneron Pharmaceuticals, to be administered to children above the age of 12 and adults, including those over 65 with underlying health conditions, as part of a therapy to stop their condition from worsening. Justifying the move, the FDA cited clinical trials of coronavirus patients, which indicated the antibodies reduced h
Hence then, the article about fda grants emergency use authorization for experimental regeneron covid 19 cocktail given to trump was published today ( ) and is available onRussia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( FDA grants emergency use authorization for experimental Regeneron Covid-19 cocktail given to Trump )